Auto-Injectors Auto-Injectors- Picture Courtesy: PDD Innovation It is the latest innovation in the drug delivery system and is favored by patients because it automates the administration process
If there are signs of NAD+ deficiency, such as in pellagra, which manifests as dermatitis, dementia, or diarrhea, supplemental IV NAD therapy may be warranted
Where These Numbers Come From NAD+ replenishment targets several interconnected aging pathways, all driven by the age-related decline in NAD+ levels: Sirtuin activation: NAD+ is required for SIRT1-7 function deacetylases that regulate DNA repair, mitochondrial biogenesis, inflammation, and stress resistance
Clinical Update 5/15/2021 Misleading Kefir Claims Recent testing of several popular kefir beverages in the U.S
Product Features
3 RGN-259 Phase 3 Trial in Neurotrophic Keratopathy Sosne et al., International Journal of Molecular Sciences (2022) This Phase 3 randomized, placebo-controlled, double-masked clinical trial evaluated topical 0.1% RGN-259 (full-length recombinant T4 ophthalmic solution) in patients with neurotrophic keratopathy